Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously demonstrated that
FGD1
, the Cdc42 guanine nucleotide exchange factor (GEF) responsible for faciogenital dysplasia, is targeted by the ubiquitin ligase SCF(FWD1/beta-TrCP) upon phosphorylation of two serine residues in its DSGIDS motif and subsequently degraded by the
proteasome
. Here we show that FGD3, which was identified as a homologue of
FGD1
but has been poorly characterized, has conserved the same motif and is down-regulated similarly by SCF(FWD1/beta-TrCP). Although FGD3 and
FGD1
share strikingly similar Dbl homology (DH) domains and adjacent pleckstrin homology (PH) domains, both of which are responsible for guanine nucleotide exchange, there also exist remarkable differences in their structures. Indeed,
FGD1
and FGD3 induced significantly different morphological changes in HeLa Tet-Off cells: whereas
FGD1
induced long finger-like protrusions, FGD3 induced broad sheet-like protrusions when the level of GTP-bound Cdc42 was significantly increased by the inducible expression of FGD3. Furthermore,
FGD1
and FGD3 reciprocally regulated cell motility: when inducibly expressed in HeLa Tet-Off cells,
FGD1
stimulated cell migration whereas FGD3 inhibited it. Thus we demonstrate that the highly homologous GEFs,
FGD1
and FGD3 play different roles to regulate cellular functions but that their intracellular levels are tightly controlled by the same destruction pathway through SCF(FWD1/beta-TrCP).
...
PMID:Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCF(FWD1/beta-TrCP)-mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1. 1836 64
We previously demonstrated that
FGD1
, the Cdc42 guanine nucleotide exchange factor (GEF) responsible for faciogenital dysplasia, and its homologue FGD3 are targeted by the ubiquitin ligase SCF(FWD1) upon phosphorylation of two serine residues in their DSGIDS motif and subsequently degraded by the
proteasome
.
FGD1
and FGD3 share highly homologous Dbl homology (DH) and adjacent pleckstrin homology (PH) domains, both of which are responsible for GEF activity. However, their function and regulation are remarkably different. Here we demonstrate extracellular signal-responsive translocation of
FGD1
, but not FGD3. During the wound-healing process, translocation of
FGD1
to the leading edge membrane occurs in cells facing to the wound. Furthermore, epidermal growth factor (EGF) stimulates the membrane translocation of
FGD1
, but not FGD3. As the most striking difference, FGD3 lacks the N-terminal proline-rich domain that is conserved in
FGD1
, indicating that proline-rich domain may play a crucial role in signal-responsive translocation of
FGD1
. Indeed, there is a faciogenital dysplasia patient who has a missense mutation in proline-rich domain of
FGD1
, by which the serine residue at position 205 is substituted with isoleucine. When expressed in cells, the mutant
FGD1
with S(205)/I substitution fails to translocate to the membrane in response to the mitogenic stimuli. Thus we present a novel mechanism by which the activity of
FGD1
, a GEF for Cdc42, is temporally and spatially regulated in cells.
...
PMID:Proline-rich domain plays a crucial role in extracellular stimuli-responsive translocation of a Cdc42 guanine nucleotide exchange factor, FGD1. 2004 32